Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7151 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-71 |
filingDate |
2003-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52e1bbd84f99d5047ead1639c58ff052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94d6bf4a13018b8329182557f3b68df3 |
publicationDate |
2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2004191257-A1 |
titleOfInvention |
Pharmaceutical compositions comprising herpes virus entry receptor protein |
abstract |
The present invention provides isolated and purified polynucleotides that encode HVEM of mammalian origin, expression vectors containing those polynucleotides, host cells transformed with those expression vectors, a process of making HVEM using those polynucleotides and vectors, and isolated and purified HVEM. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010196386-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8318166-B2 |
priorityDate |
1995-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |